RxDoctor Payments Data

Ronald Jackups, MD

Clinical Pathology/Laboratory Medicine · Saint Louis, MONPI 1699927020

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (41.7%), consulting fees and speaking fees — rather than concentrated in one kind of arrangement. Instrumentation Laboratory Company accounts for 96.8% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2024 at $13,727 and has fallen 57.6% since, to $5,822 in 2025.

$35,942in general payments, 2019–2025

Across 42 payments — averaging $855.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Instrumentation Laboratory Company$35K
  • AstraZeneca$474
  • BD$319
  • Merck$100
  • Sanofi$93
  • Sanofi US Services Inc.$78
  • plus $78 from 3 others
$417,620in research payments, 2019–2025

Across 11 payments — averaging $37,965 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Instrumentation Laboratory Company$400K
  • Siemens Medical Solutions USA, Inc.$18K

What the payments were for

  • Consulting fees$14,80041%
  • Speaking & faculty fees$4,40012%
  • Travel & lodging$14,99442%
  • Food & beverage$1,7485%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few clinical pathology/laboratory medicine providers in Missourito place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$18,471
Medicare patients
552
Services billed
1,082

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other clinical pathology/laboratory medicine in Saint Louis

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →